ParisK: Correlation of Imaging Techniques With Histology (ParisK)

October 26, 2023 updated by: Maastricht University Medical Center

The Assessment of the Plaque at RISK by Non-invasive (Molecular) Imaging and Modelling (ParisK): Correlation of Imaging Techniques With Histology

The possibility to identify the risk of rupture of a carotid plaque will have tremendous impact in clinical decision making. A vulnerable plaque is considered to have a large lipid rich necrotic core (LRNC), a thin fibrous cap, the presence of inflammatory cells, intraplaque haemorrhage and/or neovascularisation (vasa vasorum). The investigators aim to validate imaging of plaque vulnerability with histology. Previous studies have evaluated the use of imaging to assess carotid plaque vulnerability, mostly showing a good correlation between imaging and histology and/or clinical characteristics. However, they have focused on single modalities, (magnetic resonance imaging [MRI], multidetector-row computed tomography (MDCT), ultrasonography (US) or transcranial Doppler (TCD), and have used relatively small cohorts

The primary goal of this study is to investigate whether there is a correlation between neovascularisation in the carotid atherosclerotic plaque as observed with 3.0 Tesla dynamic contrast-enhanced MRI and histology. Moreover, the investigators aim to investigate the correlation between the volume of the LRNC as determined by dual-energy CT and histology.

Secondly, the investigators will investigate the correlation between the volume of the LRNC, the fibrous cap status and the volume of the calcifications determined by MRI versus histology, the correlation between number of microembolisms and fibrous cap status and the correlation between the deformation pattern seen with ultrasound and the volume of the LRNC.

The imaging parameters showing good correlation with plaque vulnerability characteristics can be used for further analysis in assessing the vulnerable plaque

Study Overview

Study Type

Observational

Enrollment (Actual)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Limburg
      • Maastricht, Limburg, Netherlands
        • Maastricht University Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients with a carotid artery stenosis, who are scheduled for carotid endarterectomy, will be included.

Description

Inclusion Criteria:

  • Patients with a carotid artery stenosis, who are scheduled for carotid endarterectomy
  • Age 18 years or older (no maximum age)
  • Informed consent by signing informed consent form regarding this study
  • Inclusion criteria for carotid endarterectomy

    1. Symptomatic carotid artery stenosis 70-99% within 3 months of neurological symptoms
    2. Symptomatic carotid artery stenosis 50-99% in man within 2 weeks of neurological symptoms
    3. Asymptomatic carotid artery stenosis 70-99% with contralateral occlusion

Exclusion Criteria:

  • Severe co-morbidity, dementia or pregnancy
  • Standard contra-indications for MRI (ferromagnetic implants like pacemakers or other electronic implants, metallic eye fragments, vascular clips, claustrophobia, etc.)
  • Patients who have a documented allergy to MRI or CT contrast media
  • Patients with a renal clearance <30 ml/min are not eligible to undergo contrast-enhanced MRI
  • Patients with a renal clearance <60 ml/min are not eligible to undergo CT
  • Surgery planned within 4 days of inclusion

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients scheduled for CEA
All patients who are scheduled for carotid endarterectomy (CEA)
Other Names:
  • Philips IU22
Multi-sequence MR protocol
Other Names:
  • 3.0 T Philips Achieva
Other Names:
  • Siemens Flash
Other Names:
  • Hemodynamics AG

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ktrans on dynamic contrast-enhanced (DCE)-MRI
Time Frame: 1 day
The correlation between neovascularisation in carotid atherosclerotic plaque as assessed by dynamic 3.0 Tesla MRI and microvasculature as assessed by histology.
1 day
Lipid-rich necrotic core on dual-energy CT
Time Frame: 1 day
The correlation between the size of lipid-rich-necrotic-core in dual-energy CT and histology.
1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
deformation pattern on ultrasound
Time Frame: 1 day
The correlation between deformation pattern at echo and plaque composition (volume of LRNC) at histology.
1 day
number of recorded micro embolic signals (MES)
Time Frame: 1 day
The relation between number of recorded MES and fibrous cap status at histology.
1 day
Volume of LRNC and calcifications and fibrous cap status on MRI
Time Frame: 1 day
The correlation between volume of LRNC, fibrous cap status and volume of calcifications in carotid atherosclerotic plaques visualised by MRI and the same features as determined at histology.
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Eline Kooi, PhD, Maastricht University Medical Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2011

Primary Completion (Actual)

December 1, 2014

Study Completion (Actual)

December 1, 2014

Study Registration Dates

First Submitted

October 16, 2012

First Submitted That Met QC Criteria

October 16, 2012

First Posted (Estimated)

October 17, 2012

Study Record Updates

Last Update Posted (Actual)

October 27, 2023

Last Update Submitted That Met QC Criteria

October 26, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 10-2-048

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Ultrasound

Subscribe